|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bodner-Adler B, Bodner K, Obermair A,
Czerwenka K, Petru E, Leodolter S and Mayerhofer K: Prognostic
parameters in carcinosarcomas of the uterus: A clinico-pathologic
study. Anticancer Res. 21:3069–3074. 2001.PubMed/NCBI
|
|
4
|
Sanz-Chávez TL, Vilar-Compte D, de
Nicola-Delfín L and Meneses-García A: Overweight, obesity,
diabetes, and hypertension in endometrial cancer. Rev Med Inst Mex
Seguro Soc. 51:326–329. 2013.(In Spanish). PubMed/NCBI
|
|
5
|
Hursting SD and Berger NA: Energy balance,
host-related factors, and cancer progression. J Clin Oncol.
28:4058–4065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Tian JW, Xu Y and Cheng W: Role of
transvaginal contrast-enhanced ultrasound in the early diagnosis of
endometrial carcinoma. Chin Med J. 125:416–421. 2012.PubMed/NCBI
|
|
7
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen WJ, Liu Y, Sui YB, Zhang B, Zhang XH
and Yin XH: Increased circulating levels of musclin in newly
diagnosed type 2 diabetic patients. Diab Vasc Dis Res. 14:116–121.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bristow RE: Endometrial cancer. Curr Opin
Oncol. 11:388–393. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clement PB and Young RH: Endometrioid
carcinoma of the uterine corpus: A review of its pathology with
emphasis on recent advances and problematic aspects. Adv Anat
Pathol. 9:145–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lukanova A, Lundin E, Micheli A, Arslan A,
Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, et al:
Circulating levels of sex steroid hormones and risk of endometrial
cancer in postmenopausal women. Int J Cancer. 108:425–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lax SF, Pizer ES, Ronnett BM and Kurman
RJ: Clear cell carcinoma of the endometrium is characterized by a
distinctive profile of p53, Ki-67, estrogen, and progesterone
receptor expression. Hum Pathol. 29:551–558. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh M, Darcy KM, Brady WE, Clubwala R,
Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC,
et al: Cadherins, catenins and cell cycle regulators: Impact on
survival in a gynecologic oncology group phase II endometrial
cancer trial. Gynecol Oncol. 123:320–328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato E, Nakayama K, Nakamura K, Ishikawa
N, Ishikawa M, Minamoto T, Ishibashi T and Kyo S: Efficacy of
metformin for advanced-stage endometrial cancer: A case report. Mol
Clin Oncol. 6:441–443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trentham-Dietz A, Nichols HB, Hampton JM
and Newcomb PA: Weight change and risk of endometrial cancer. Int J
Epidemiol. 35:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu WH, Matthews CE, Xiang YB, Zheng W,
Ruan ZX, Cheng JR, Gao YT and Shu XO: Effect of adiposity and fat
distribution on endometrial cancer risk in Shanghai women. Am J
Epidemiol. 161:939–947. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mu N, Zhu Y, Wang Y, Zhang H and Xue F:
Insulin resistance: A significant risk factor of endometrial
cancer. Gynecol Oncol. 125:751–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kacalska O, Krzyczkowska-Sendrakowska M,
Milewicz T, Zabińska-Popiela M, Bereza T, Krzysiek-Maczka G and
Krzysiek J: Molecular action of insulin-sensitizing agents).
Endokrynol Pol. 56:308–313. 2005.(In Polish). PubMed/NCBI
|
|
19
|
Folsom AR, Anderson KE, Sweeney C and
Jacobs DR Jr: Diabetes as a risk factor for death following
endometrial cancer. Gynecol Oncol. 94:740–745. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shoff SM and Newcomb PA: Diabetes, body
size, and risk of endometrial cancer. Am J Epidemiol. 148:234–240.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salazar-Martínez E, Lazcano-Ponce EC,
Lira-Lira GG, Escudero-De los Rios P, Salmerón-Castro J, Larrea F
and Hernández-Avila M: Case-control study of diabetes, obesity,
physical activity and risk of endometrial cancer among Mexican
women. Cancer Causes Control. 11:707–711. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu HQ, Li Q, Rentfro AR, Fisher-Hoch SP
and McCormick JB: The definition of insulin resistance using
HOMA-IR for Americans of Mexican descent using machine learning.
PLoS One. 6:e210412011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Habib SS, Eshki A, AlTassan B, Fatani D,
Helmi H and AlSaif S: Relationship of serum novel adipokine
chemerin levels with body composition, insulin resistance,
dyslipidemia and diabesity in Saudi women. Eur Rev Med Pharmacol
Sci. 21:1296–1302. 2017.PubMed/NCBI
|
|
24
|
Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen
X and Lü B: The association between metabolic abnormality and
endometrial cancer: A large case-control study in China. Gynecol
Oncol. 117:41–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bray GA: The underlying basis for obesity:
Relationship to cancer. J Nutr. 132:3451–3455. 2002.
|
|
26
|
Akhmedkhanov A, Zeleniuch-Jacquotte A and
Toniolo P: Role of exogenous and endogenous hormones in endometrial
cancer: Review of the evidence and research perspectives. Ann N Y
Acad Sci. 943:296–315. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaaks R, Lukanova A and Kurzer MS:
Obesity, endogenous hormones, and endometrial cancer risk: A
synthetic review. Cancer Epidemiol Biomarkers Prev. 11:1531–1543.
2002.PubMed/NCBI
|
|
28
|
Osório-Costa F, Rocha GZ, Dias MM and
Carvalheira JB: Epidemiological and molecular mechanisms aspects
linking obesity and cancer. Arq Bras Endocrinol Metabol.
53:213–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takemura Y, Ouchi N, Shibata R, Aprahamian
T, Kirber MT, Summer RS, Kihara S and Walsh K: Adiponectin
modulates inflammatory reactions via calreticulin
receptor-dependent clearance of early apoptotic bodies. J Clin
Invest. 117:375–386. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higuchi A, Ohashi K, Shibata R, Sono-Ro
manelli S, Walsh K and Ouchi N: Thiazolidinediones reduce
pathological neovascularization in ischemic retina via an
adiponectin-dependent mechanism. Arterioscler Thromb Vasc Biol.
30:46–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
